ATE294172T1 - Substituierte benzocycloheptapyridine derivate verwendbar als farnesyl-protein transferase inhibitoren - Google Patents

Substituierte benzocycloheptapyridine derivate verwendbar als farnesyl-protein transferase inhibitoren

Info

Publication number
ATE294172T1
ATE294172T1 AT97941476T AT97941476T ATE294172T1 AT E294172 T1 ATE294172 T1 AT E294172T1 AT 97941476 T AT97941476 T AT 97941476T AT 97941476 T AT97941476 T AT 97941476T AT E294172 T1 ATE294172 T1 AT E294172T1
Authority
AT
Austria
Prior art keywords
protein transferase
farnesyl
transferase inhibitors
cells
independently selected
Prior art date
Application number
AT97941476T
Other languages
German (de)
English (en)
Inventor
Dinanath F Rane
Alan B Cooper
Alan K Mallams
Ronald J Doll
F George Njoroge
Arthur G Taveras
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE294172T1 publication Critical patent/ATE294172T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pyridine Compounds (AREA)
AT97941476T 1996-09-13 1997-09-11 Substituierte benzocycloheptapyridine derivate verwendbar als farnesyl-protein transferase inhibitoren ATE294172T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71370596A 1996-09-13 1996-09-13
PCT/US1997/015902 WO1998011097A1 (en) 1996-09-13 1997-09-11 Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase

Publications (1)

Publication Number Publication Date
ATE294172T1 true ATE294172T1 (de) 2005-05-15

Family

ID=24867191

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97941476T ATE294172T1 (de) 1996-09-13 1997-09-11 Substituierte benzocycloheptapyridine derivate verwendbar als farnesyl-protein transferase inhibitoren

Country Status (13)

Country Link
EP (1) EP0931077B1 (https=)
JP (1) JP2001500506A (https=)
KR (1) KR20000036102A (https=)
CN (1) CN1104428C (https=)
AT (1) ATE294172T1 (https=)
AU (1) AU4337597A (https=)
CA (1) CA2264666A1 (https=)
DE (1) DE69733142T2 (https=)
ES (1) ES2242232T3 (https=)
HU (1) HUP0000073A3 (https=)
IL (1) IL128926A0 (https=)
NZ (1) NZ334341A (https=)
WO (1) WO1998011097A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2318088A1 (en) 1998-01-21 1999-07-29 Yoshisuke Nakasato Chemokine receptor antagonists and methods of use therefor
AU2331999A (en) 1998-01-21 1999-08-09 Kyowa Hakko Kogyo Co. Ltd. Chemokine receptor antagonists and methods of use therefor
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
WO2005017160A2 (en) 2003-08-13 2005-02-24 Children's Hospital Medical Center Mobilization of hematopoietic cells
WO2007002254A2 (en) 2005-06-23 2007-01-04 Merck & Co., Inc. Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
TW200813021A (en) 2006-07-10 2008-03-16 Merck & Co Inc Tyrosine kinase inhibitors
CA2657247A1 (en) 2006-07-28 2008-01-31 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
CA2704684A1 (en) 2007-11-07 2009-05-14 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
US8178568B2 (en) 2008-07-10 2012-05-15 Boehringer Ingelheim International Gmbh Sulfone compounds which modulate the CB2 receptor
CA2737639A1 (en) 2008-09-25 2010-04-01 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the cb2 receptor
JP5705748B2 (ja) 2009-02-18 2015-04-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Cb2受容体を変調する複素環化合物
US8299103B2 (en) 2009-06-15 2012-10-30 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the CB2 receptor
JP5756800B2 (ja) * 2009-06-16 2015-07-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Cb2受容体を調節するアゼチジン2−カルボキサミド誘導体
WO2011037795A1 (en) 2009-09-22 2011-03-31 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the cb2 receptor
WO2011088015A1 (en) 2010-01-15 2011-07-21 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
US8329735B2 (en) 2010-03-05 2012-12-11 Boehringer Ingelheim International Gmbh Tetrazole compounds which selectively modulate the CB2 receptor
WO2012012307A1 (en) 2010-07-22 2012-01-26 Boehringer Ingelheim International Gmbh Sulfonyl compounds which modulate the cb2 rece
EP2803668A1 (en) 2013-05-17 2014-11-19 Boehringer Ingelheim International Gmbh Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593417A (en) * 1976-12-22 1981-07-15 Squibb & Sons Inc Carbocyclic-fused pyrazolopyridine derivatives
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
IE68935B1 (en) * 1990-06-22 1996-07-24 Schering Corp Bis-benzo or benzopyrido cyclohepta piperidene piperidylidene and piperazine compounds compositions and methods of use
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
CA2174105C (en) * 1993-10-15 2002-02-12 W. Robert Bishop Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases

Also Published As

Publication number Publication date
NZ334341A (en) 2001-01-26
HUP0000073A3 (en) 2002-02-28
JP2001500506A (ja) 2001-01-16
HUP0000073A2 (hu) 2001-10-28
DE69733142D1 (de) 2005-06-02
EP0931077A1 (en) 1999-07-28
CN1104428C (zh) 2003-04-02
DE69733142T2 (de) 2006-03-16
KR20000036102A (ko) 2000-06-26
EP0931077B1 (en) 2005-04-27
CN1236365A (zh) 1999-11-24
ES2242232T3 (es) 2005-11-01
AU4337597A (en) 1998-04-02
IL128926A0 (en) 2000-02-17
WO1998011097A1 (en) 1998-03-19
CA2264666A1 (en) 1998-03-19

Similar Documents

Publication Publication Date Title
ATE294172T1 (de) Substituierte benzocycloheptapyridine derivate verwendbar als farnesyl-protein transferase inhibitoren
ATE345338T1 (de) Tricyclische piperdinyl derivate verwendbar als farnesyl-protein transferase inhibitoren
ATE242231T1 (de) Carbonyl-piperaznyl und piperidinyl derivate zur hemmung farnesyl protein transferase
BR0005633A (pt) Derivados de quinolina úteis para inibição da farnesil proteìna transferase
MY117290A (en) Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation
ATE286046T1 (de) Trizyklische inhibitoren der farnesyl protein transferase
SE8303824L (sv) N-imidazolylderivat av bicykliska foreningar och forfarande for deras framstellning
ES2120728T3 (es) Inhibidores de la agregacion de plaquetas.
NO991230L (no) Trisykliske forbindelser for inhibering av G-proteinfunksjon og for behandling av proliferative sykdommer
ATE356816T1 (de) Trizyklische keto amid derivative als farnesyl protein transferase inhibitoren
NO991235L (no) Forbindelser anvendelige for inhibering av farnesylproteintransferase
CA2293358A1 (en) Tricyclic sulfonamide inhibitors of farnesyl-protein transferase
ATE299140T1 (de) Farnesyl-protein transferase inhibitoren
EA200001248A1 (ru) Новые линейные и циклические производные мочевины, способ их получения и их содержащие фармацевтические композиции
DE69721588D1 (de) Tricyclische verbindungen als ras-fpt inhibitoren
ATE218137T1 (de) Benzo(5,6)cyclohepta(1,2-b)pyridin derivate als farnesyl protein transferase inhibitoren
US5712261A (en) Method for preventing or treating hypertriglyceridemia
DE69014337D1 (de) Verwendung von 5-Alkylpyridazin-Derivaten als Medikamente zur Beeinflussung des cholinergen Systems.
DK614989A (da) Indolderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
ID19401A (id) N-sianoimina trisiklik baru yang berguna sebagai inhibitor farnesil-protein transferase
DE69626846D1 (de) Phosphonsäurederivate mit metallopeptidase inhibierender aktivität
ATE236149T1 (de) Tricyclische aminooxyamide derivate als farnesyl protein transferase inhibitoren
ATE248831T1 (de) Benzo(5,6)cyclohepta(1,2b)pyridine derivate anwendbar als farnesyl protein transferase inhibitoren
NO991232D0 (no) Substituerte benzosykloheptapyridinderivater anvendelige for inhibering av farnesylproteintransferase
CO4940474A1 (es) Compuestos utiles para la inhibicion de transferasa de proteina farnesilo

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties